Rapid deployment of inexpensive open-source orbital shakers in support of high-throughput screening.

3D printing Cellular suspension HTS Open-source Orbital Shaker

Journal

SLAS technology
ISSN: 2472-6311
Titre abrégé: SLAS Technol
Pays: United States
ID NLM: 101697564

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 24 1 2022
medline: 10 6 2022
entrez: 23 1 2022
Statut: ppublish

Résumé

Open-source projects continue to grow in popularity alongside open-source educational resources, software, and hardware tools. The impact of this increased availability of open-source technologies is that end users are empowered to have greater control over the tools that they work with. This trend extends in the life science laboratory space, where new open-source projects are routinely being published that allow users to build and modify scientific equipment specifically tailored to their needs, often at a reduced cost from equivalent commercial offerings. Recently, we identified a need for a compact orbital shaker that would be usable in temperature and humidity-controlled incubators to support the development and execution of a high-throughput suspension cell-based assay. Based on the requirements provided by staff biologists, an open-source project known as the DIYbio orbital shaker was identified on Thingiverse, then quickly prototyped and tested. The initial orbital shaker prototype based on the DIYbio design underwent an iterative prototyping and design process that proved to be straightforward due to the open-source nature of the project. The result of these efforts has been the successful initial deployment of ten shakers as of August 2021. This afforded us the scalability and efficacy needed to complete a large-scale screening campaign in less time and at less cost than if we purchased larger, less adaptable orbital shakers. Lessons learned from prototyping, modifying, validating, deploying and maintaining laboratory devices based on an open-source design in support of a full-scale drug discovery high-throughput screening effort are described within this manuscript.

Identifiants

pubmed: 35066236
pii: S2472-6303(22)00003-6
doi: 10.1016/j.slast.2022.01.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-186

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Pierre Baillargeon (P)

The Scripps Research Molecular Screening Center, Department of Molecular Medicine, Scripps Florida, 130 Scripps Way, Jupiter, Florida, USA.

Virneliz Fernandez-Vega (V)

The Scripps Research Molecular Screening Center, Department of Molecular Medicine, Scripps Florida, 130 Scripps Way, Jupiter, Florida, USA.

Luis Ortiz (L)

The Scripps Research Molecular Screening Center, Department of Molecular Medicine, Scripps Florida, 130 Scripps Way, Jupiter, Florida, USA.

Justin Shumate (J)

The Scripps Research Molecular Screening Center, Department of Molecular Medicine, Scripps Florida, 130 Scripps Way, Jupiter, Florida, USA.

Nicholas Marques (N)

The Scripps Research Molecular Screening Center, Department of Molecular Medicine, Scripps Florida, 130 Scripps Way, Jupiter, Florida, USA.

Lynn Deng (L)

The Scripps Research Molecular Screening Center, Department of Molecular Medicine, Scripps Florida, 130 Scripps Way, Jupiter, Florida, USA.

Timothy P Spicer (TP)

The Scripps Research Molecular Screening Center, Department of Molecular Medicine, Scripps Florida, 130 Scripps Way, Jupiter, Florida, USA.

Louis Scampavia (L)

The Scripps Research Molecular Screening Center, Department of Molecular Medicine, Scripps Florida, 130 Scripps Way, Jupiter, Florida, USA. Electronic address: scampl@scripps.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH